|
|
Article: Merck Cancels Work on a New Insomnia Medication - New York Times
- Article from:
- The New York Times
- Article date:
- March 29, 2007
|
Copyright information (Hide copyright information)
|
Two weeks after the Food and Drug Administration issued safety warnings about widely used sleeping pills, the drug maker Merck canceled a venture into the shifting market for insomnia medications. Merck and its Danish partner, H. Lundbeck, announced that a safe and effective sleeping pill had eluded their scientists after years of study, and they canceled their joint product, gaboxadol. Unusual side effects - including hallucinations and disorientation - showed up in the studies. The drug also failed a trial of its efficacy.During a conference call yesterday, Lundbeck's senior vice president for drug development, Anders Gersel Pedersen, said, "We did not want to bring a product to the ...
Related newspaper, magazine, and journal articles:
|
|
Article: Risks spur Merck to pull painkiller off market.
Knight Ridder/Tribune Business News;
October 1, 2004 ;
700+ words
......Business News Oct. 1--Merck & Co. withdrew...painkiller Vioxx from the market Thursday after finding...for a company of Merck's size. Thursday...nearly $27 billion in market value, slightly less than the entire market value of Kenilworth...down 56 points. A Merck spokesman said ...
|
|